SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Palliser Capital (UK) Ltd

CIK 0001881490 · PALLISER HOUSE, PALLISER ROAD, LONDON, X0, W14 9EQ · 00442081591101

Reported Value
$88M
Q1 2023
Positions
7
Filings on Record
18
2019–present window
Filed
Apr 14, 2023
original filing

Summary

Palliser Capital (UK) Ltd reported $88M in U.S.-listed holdings across 7 positions for Q1 2023.

The portfolio is heavily concentrated: ACI alone accounts for 35.5% of reported value.

Compared with Q4 2022, the fund opened 2 new positions and exited 4.

Portfolio Metrics

Turnover
+16.0%
vs prior filed quarter
Largest Position
+35.5%
Albertsons Cos
New / Exited
2 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $118MQ4 ’21Q1 ’22: $68MQ2 ’22: $68MQ3 ’22: $62MQ3 ’22Q4 ’22: $41MQ1 ’23: $88MQ2 ’23: $99MQ2 ’23Q3 ’23: $63MQ4 ’23: $65MQ1 ’24: $73MQ1 ’24Q2 ’24: $100MQ3 ’24: $148MQ4 ’24: $125MQ4 ’24Q1 ’25: $85MQ2 ’25: $137MQ3 ’25: $136MQ3 ’25Q4 ’25: $147MQ1 ’26: $129Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 75.3%ADR: 14.4%Other: 10.3%
  • Common Stock · 75.3% · $67M
  • ADR · 14.4% · $13M
  • Other · 10.3% · $9M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
RIORIO TINTO PLCNEW+147.7K147.7K+$10M$10M
HORIZON THERAPEUTICS PUB LNEW+83.5K83.5K+$9M$9M
ACIALBERTSONS COS INCADDED+1.41M1.51M+$29M$31M
SJIEURSOUTH JERSEY INDS INCSOLD OUT226.8K0$8M$0
THERAVANCE BIOPHARMA INCSOLD OUT97.1K0$1M$0
EURONAV NVSOLD OUT33.7K0$574,299$0
SIMOSILICON MOTION TECHNOLOGY COSOLD OUT8.0K0$519,985$0
CNNECANNAE HLDGS INCADDED+222.7K522.9K+$4M$11M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

7 positions
#IssuerClass% PortfolioValueShares
1ACIALBERTSONS COS INChistory →COMMON STOCK35.50%$31M1.51M
2ATVIEURACTIVISION BLIZZARD INChistory →COM24.16%$21M249.4K
3CNNECANNAE HLDGS INChistory →COM11.94%$11M522.9K
4RIORIO TINTO PLChistory →SPONSORED ADR11.47%$10M147.7K
5HORIZON THERAPEUTICS PUB LSHS10.32%$9M83.5K
6POH3CARNIVAL PLChistory →ADR3.68%$3M355.7K
7TSMTAIWAN SEMICONDUCTOR MFG LTDhistory →SPONSORED ADS2.92%$3M27.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$129M5May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$147M5Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$136M6Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$137M5Jul 29, 202513F-HRchanges · EDGAR ↗
Q1 2025$85M3May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$125M6Jan 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$148M11Oct 28, 202413F-HRchanges · EDGAR ↗
Q2 2024$100M10Jul 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$73M10Apr 17, 202413F-HRchanges · EDGAR ↗
Q4 2023$65M6Jan 8, 202413F-HRchanges · EDGAR ↗
Q3 2023$63M6Oct 11, 202313F-HRchanges · EDGAR ↗
Q2 2023$99M7Jul 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$88M7Apr 14, 202313F-HRchanges · EDGAR ↗
Q4 2022$41M9Jan 17, 202313F-HRchanges · EDGAR ↗
Q3 2022$62M10Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$68M9Aug 1, 202213F-HRchanges · EDGAR ↗
Q1 2022$68M8Apr 20, 202213F-HRchanges · EDGAR ↗
Q4 2021$118M8Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.